Table I.
Participant demographics and baseline characteristics
| Baseline characteristic | Pooled population (N = 1127)∗ |
|---|---|
| Age (y), median (range) | 9.0 (4-17) |
| Age category (y), no. (%) | |
| 4-11 | 753 (66.8) |
| 12-17 | 374 (33.2) |
| Sex, no. (%) | |
| Male | 675 (59.9) |
| Female | 452 (40.1) |
| Race, no. (%) | |
| White | 848 (75.2) |
| Other | 268 (23.8) |
| History of allergic rhinitis, no. (%)† | 785 (69.7) |
| History of asthma, no. (%)† | 551 (48.9) |
| History of atopic dermatitis, no. (%)† | 666 (59.1) |
| Other food allergies, no. (%)† | 709 (62.9) |
| Peanut SPT average wheal diameter (mm) | |
| No. of patients | 1075 |
| Median (Q1, Q3) | 11.5 (9.0, 15.5) |
| Peanut-specific IgE level (kUA/L) | |
| No. of patients | 937 |
| Median (Q1, Q3) | 83.9 (30.0, 205.0) |
Q, Quartile.
∗
Baseline data were taken from the trial in which a participant was first treated with PTAH.
†
Participants may be included in more than 1 category.